TOKYOMEDIJAPAN MEDICAL REFERENCE
⌕ Search databaseOfficial source · PMDA / MHLW
Rx · Reference only · no online purchase

Pirespa (Pirfenidone)

Pirespa / Pirfenidone. Used for idiopathic pulmonary fibrosis.

PMDAproduct-level source2022-03label updated2026-10-05site verified
ピレスパ錠200mg · 200 mg
Japanese product photo · 200 mg · 塩野義製薬
Main useUsed for idiopathic pulmonary fibrosis.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
Japan product name
ピレスパ錠200mg
Brand
Pirespa
Generic name
Pirfenidone
Japanese generic name
ピルフェニドン
Chinese name
吡非尼酮
Marketing authorization holder
塩野義製薬株式会社
Strengths
200 mg
Dosage form
tablet
Therapeutic area
Respiratory
Regulatory status
Rx
Label updated
2022-03
TOKYO MEDI verified
2026-10-05
MEDICINE REFERENCE

Detailed product reference

Summaries refer to the listed Japanese product. Eligibility, adjustments and full risks depend on its label and strength; a clinician determines individual treatment.

01

Product overview

Pirespa is an antifibrotic for idiopathic pulmonary fibrosis, supplied in Japan as 200 mg tablets.

Read source section ↗
02

Mechanism of action

Modulates fibrotic pathways and collagen production; its mechanism is not reducible to one proven clinical target.

Read source section ↗
03

Japanese indications & eligibility

The Japanese indication is idiopathic pulmonary fibrosis; other fibrotic lung diseases require separate assessment.

Read source section ↗
04

Administration & dose differences

Start 200 mg three times daily after meals and titrate toward 600 mg three times daily according to tolerance.

Read source section ↗
05

Adverse effects & key risks

Important concerns include photosensitivity, GI intolerance, liver injury and blood-cell abnormalities.

Read source section ↗
06

Contraindications & special populations

Ingredient hypersensitivity is contraindicated; assess liver/kidney function, pregnancy and dizziness-related safety.

Read source section ↗
07

Drug interactions

CYP1A2 modifiers such as fluvoxamine/ciprofloxacin and changes in smoking affect exposure.

Read source section ↗
08

Assessment & monitoring

Monitor liver function, blood counts, weight/nutrition and respiratory function.

Read source section ↗
09

Storage & handling

Store at room temperature; the photo is the Japanese 200 mg blister.

Read source section ↗
10

Sources & verification

Product checked ·

Official source

These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.